PCL-TCP Composite for Bone Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current polymer-ceramic composites for bone regeneration face challenges such as mechanical instability, limited ceramic content, and toxicity from solvents, which hinder effective bone integration and regeneration.
Innovation Solution
A biocompatible polymer-ceramic composite with a ratio of 3:1 to 1:3 by weight, incorporating tricalcium phosphate (TCP) and polycaprolactone (PCL), featuring improved printability, elastic modulus, and accelerated degradation, with reduced solvent content, and a structured design for 3D printing, including a porous core and non-porous shell for enhanced bone integration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If TCP content is increased to improve bone regeneration, then bone integration is enhanced, but mechanical stability deteriorates
Solution Approach 1:
The patent uses a composite material system combining PCL polymer and TCP ceramic particles. The polymer matrix provides mechanical stability and flexibility, while the ceramic particles contribute bone regeneration properties. This composite approach allows simultaneous achievement of both mechanical stability and bone integration by leveraging the complementary properties of different materials.
Solution Approach 2:
The patent optimizes the weight ratio of PCL to TCP (specifically 70:30 or 80:20) to balance mechanical properties and bone regeneration capability. By carefully controlling the concentration and distribution of TCP particles within the polymer matrix, the patent achieves optimal mechanical stability while maintaining sufficient ceramic content for effective bone integration.
2Reliability
If TCP content is increased beyond 20% to enhance bone regeneration, then bone integration improves, but material processability deteriorates
Solution Approach 1:
The patent maintains a specific PCL:TCP weight ratio (70:30 or 80:20) that allows the composite to be extruded through standard 3D printing nozzles while incorporating sufficient TCP (30% or 20%) for effective bone regeneration. This parameter optimization enables both high ceramic content and good processability.
Solution Approach 2:
The patent ensures uniform distribution of TCP particles throughout the PCL matrix, creating consistent local properties that facilitate smooth extrusion and printing. The localized dispersion of ceramic particles prevents aggregation and maintains material flowability during 3D printing while still providing sufficient ceramic content for bone regeneration.
3Ease of operation
If solvent is used to improve material extrudability, then printability is enhanced, but cell toxicity increases
Solution Approach 1:
The patent removes or minimizes the use of toxic solvents in the ink formulation. By developing a solvent-free or low-solvent system, the patent eliminates the source of cell toxicity while maintaining material extrudability through optimized polymer-ceramic composite properties and appropriate extrusion parameters.
Solution Approach 2:
The patent uses biocompatible, biodegradable PCL polymer that can be processed without persistent toxic solvents. The material system is designed to be extrudable in its native state or with minimal processing aids that do not pose long-term toxicity risks to cells or tissue.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composite demonstrates improved mechanical properties, accelerated degradation, and increased water uptake, facilitating effective bone regeneration and integration, with the structured design promoting better tissue ingrowth and vascularization without the need for additional growth factors or stem cells.
Implementation Method 1
a biodegradable polyester that has been utilized in medicine for many years
Implementation Method 2
the composite of polymer and ceramic has increased water uptake as compared to a composite having a higher ratio of biocompatible polymer:biocompatible ceramic
Data Source
AI summary
Provided herein are improved compositions and methods of making and using the same, the composition comprising a polymer and a ceramic present at a ratio of from 3:1 to 1:3 of polymer:ceramic by weight, wherein the composition comprises or is a composite of the polymer and the ceramic having improved printability and/or having an improved elastic modulus and/or improved stress at failure (e.g., as compared to a blend of the polymer and the ceramic). Improved medical implants incorporating the same are also provided.